Skip to main content
. Author manuscript; available in PMC: 2021 Feb 4.
Published in final edited form as: Nature. 2020 Jun 24;583(7815):265–270. doi: 10.1038/s41586-020-2435-1

Extended Data Table 1. A lesion segregation based test for oncogenic selection.

Strain Gene Mutation Mutation count Odds ratio P-value Known driver
C3H Braf 6:37548568_A/T 151 2.13 5.77x10-6 Yes
C3H Hras 7:145859242_T/C 81 2.67 6.88x10-6 Yes
C3H Hras 7:145859242_T/A 65 1.02 1 Yes
C3H Intronic Fmnl1 11:105081902_A/C 44 1.03 1 No
C3H Intergenic 9:73125689_G/C 42 1.13 1 No
C3H Egfr 11:14185624_T/A 34 3.87 1.23x10-4 Yes
CAST Braf 6:37451282_A/T 42 1.41 0.338 Yes

Recurrently mutated sites in both C3H and CAST with sufficient estimated power to detect oncogenic selection through biased strand retention analysis (required >33 C3H recurrences or >41 CAST recurrences). Odds ratio values >1 indicate the predicted correlation of driver mutation and Watson/Crick strand retention in tumours with the candidate driver mutation, but not for those without the mutation. The Fisher’s exact test P-value is shown after Bonferroni correction. Known driver indicates the mutation or its orthologous change has previously been implicated as a driver of hepatocellular carcinoma6. The CAST 6:37451282_A/T mutation is orthologous to the C3H 6:37548568_A/T mutation.